S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
GOOGL   1,419.86 (-4.29%)
AMZN   2,009.29 (-4.14%)
CGC   20.30 (-7.22%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
BAC   32.73 (-4.74%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
GOOGL   1,419.86 (-4.29%)
AMZN   2,009.29 (-4.14%)
CGC   20.30 (-7.22%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
BAC   32.73 (-4.74%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
GOOGL   1,419.86 (-4.29%)
AMZN   2,009.29 (-4.14%)
CGC   20.30 (-7.22%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
BAC   32.73 (-4.74%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
GOOGL   1,419.86 (-4.29%)
AMZN   2,009.29 (-4.14%)
CGC   20.30 (-7.22%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
BAC   32.73 (-4.74%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
Log in

Ovid Therapeutics SEC Filings & 10K Form (NASDAQ:OVID)

$3.46
-0.08 (-2.26 %)
(As of 02/24/2020 04:00 PM ET)
Today's Range
$3.37
Now: $3.46
$3.50
50-Day Range
$3.38
MA: $3.77
$4.35
52-Week Range
$1.53
Now: $3.46
$5.24
Volume653,324 shs
Average Volume545,298 shs
Market Capitalization$165.44 million
P/E RatioN/A
Dividend YieldN/A
Beta2.86

SEC Filings

Ovid Therapeutics (NASDAQ:OVID) SEC Filings

DateFilerForm TypeView
02/14/2020
1:29 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Ovid Therapeutics (Subject)
Form SC 13G/A
02/14/2020
8:29 AM
During Matthew (Filed by)
Ovid Therapeutics (Subject)
Form SC 13G/A
02/14/2020
8:26 AM
LEVIN JEREMY M (Filed by)
Ovid Therapeutics (Subject)
Form SC 13G/A
01/07/2020
7:05 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2020
6:47 PM
Ovid Therapeutics (Issuer)
Perone Thomas Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2019
3:29 PM
Ovid Therapeutics (Issuer)
Rakhit Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2019
3:24 PM
LEVIN JEREMY M (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2019
3:21 PM
Haasner Dirk (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2019
12:15 PM
Ovid Therapeutics (Subject)
TLS Advisors LLC (Filed by)
Form SC 13D/A
11/22/2019
5:23 AM
MILLENNIUM PHARMACEUTICALS INC (Reporting)
Ovid Therapeutics (Issuer)
TAKEDA PHARMACEUTICAL CO LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2019
5:21 AM
Ovid Therapeutics (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
Form SC 13G/A
11/22/2019
5:19 AM
MILLENNIUM PHARMACEUTICALS INC (Reporting)
Ovid Therapeutics (Issuer)
TAKEDA PHARMACEUTICAL CO LTD (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/22/2019
5:16 AM
Ovid Therapeutics (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
Form SC 13G/A
11/21/2019
7:59 AM
Ovid Therapeutics (Issuer)
Tardio Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2019
7:57 AM
Ovid Therapeutics (Issuer)
Tardio Jason (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/15/2019
3:26 PM
Friedman Bart (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2019
3:24 PM
Duncan Barbara Gayle (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2019
3:22 PM
Bernstein Karen (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
7:02 AM
Ovid Therapeutics (Filer)
Form 424B5
11/08/2019
7:23 AM
Ovid Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2019
7:05 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2019
4:46 PM
Ovid Therapeutics (Issuer)
Rakhit Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
4:43 PM
Daly Timothy (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2019
7:23 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2019
7:32 PM
LEVIN JEREMY M (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2019
8:35 PM
Ovid Therapeutics (Filer)
Form 424B5
10/07/2019
8:33 PM
Ovid Therapeutics (Filer)
Form 424B5
10/07/2019
8:29 PM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2019
12:12 PM
Ovid Therapeutics (Subject)
TLS Advisors LLC (Filed by)
Form SC 13D/A
10/03/2019
3:11 PM
Ovid Therapeutics (Filer)
Form 424B5
09/23/2019
8:54 PM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2019
7:00 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2019
8:40 PM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2019
7:10 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
4:31 PM
Ovid Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/07/2019
4:01 PM
Ovid Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2019
3:39 PM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2019
7:28 PM
Friedman Bart (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2019
4:01 PM
Ovid Therapeutics (Issuer)
WILLIAMS DOUGLAS E (Reporting)
Form 4/A
08/01/2019
4:00 PM
Duncan Barbara Gayle (Reporting)
Ovid Therapeutics (Issuer)
Form 4/A
08/01/2019
3:58 PM
Bernstein Karen (Reporting)
Ovid Therapeutics (Issuer)
Form 4/A
07/02/2019
7:05 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2019
11:04 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2019
7:05 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2019
7:10 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2019
3:30 PM
Ovid Therapeutics (Filer)
Form 8-K/A
06/10/2019
4:26 PM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2019
3:24 PM
Ovid Therapeutics (Issuer)
WILLIAMS DOUGLAS E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:21 PM
Duncan Barbara Gayle (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:19 PM
Bernstein Karen (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
4:29 PM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2019
3:35 PM
Ovid Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2019
7:05 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2019
4:30 PM
Ovid Therapeutics (Filer)
Form DEFA14A
04/24/2019
4:25 PM
Ovid Therapeutics (Filer)
Form DEF 14A
04/08/2019
7:30 PM
Ovid Therapeutics (Issuer)
Perone Thomas Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
3:43 PM
Ovid Therapeutics (Issuer)
Rakhit Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
3:42 PM
During Matthew (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2019
11:27 AM
Ovid Therapeutics (Filer)
Form 8-K/A
03/28/2019
7:02 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2019
8:55 PM
Ovid Therapeutics (Issuer)
Perone Thomas Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/21/2019
7:02 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2019
1:51 PM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2019
3:29 PM
BlackRock Inc. (Filed by)
Ovid Therapeutics (Subject)
Form SC 13G/A
03/07/2019
3:13 PM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2019
4:26 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Ovid Therapeutics (Subject)
Form SC 13G
03/01/2019
12:23 PM
Ovid Therapeutics (Subject)
TLS Advisors LLC (Filed by)
Form SC 13D
02/28/2019
7:15 PM
Bernstein Karen (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
8:56 PM
Ovid Therapeutics (Issuer)
Rakhit Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
8:54 PM
Daly Timothy (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
8:44 PM
Ovid Therapeutics (Issuer)
Ward Ana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
8:43 PM
Haasner Dirk (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
8:42 PM
LEVIN JEREMY M (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
8:42 PM
During Matthew (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
8:24 PM
Ovid Therapeutics (Filer)
Form 424B5
02/21/2019
8:22 PM
Ovid Therapeutics (Filer)
Form 424B5
02/21/2019
3:53 PM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2019
3:04 PM
Ovid Therapeutics (Filer)
Form 424B5
02/19/2019
3:01 PM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2019
11:00 AM
FMR LLC (Filed by)
Ovid Therapeutics (Subject)
Form SC 13G/A
01/07/2019
5:31 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2019
1:56 PM
Ovid Therapeutics (Subject)
SINGER JAMES R (Filed by)
Form SC 13G
01/04/2019
7:03 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2018
7:05 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2018
3:20 PM
ARMISTICE CAPITAL, LLC (Filed by)
Ovid Therapeutics (Subject)
Form SC 13G
12/06/2018
7:05 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2018
7:13 AM
Ovid Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2018
6:40 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2018
9:25 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2018
11:00 PM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2018
3:31 PM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2018
5:28 PM
Ovid Therapeutics (Issuer)
Ward Ana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2018
5:27 PM
Daly Timothy (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2018
5:26 PM
Ovid Therapeutics (Issuer)
Rakhit Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2018
5:24 PM
Haasner Dirk (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2018
8:24 PM
Bernstein Karen (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2018
8:22 PM
Ovid Therapeutics (Issuer)
WILLIAMS DOUGLAS E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2018
3:48 PM
Ovid Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2018
3:31 PM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2018
6:16 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 2/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel